Literature DB >> 10454724

Comparison of maximal voluntary isometric contraction and Drachman's hand-held dynamometry in evaluating patients with amyotrophic lateral sclerosis.

M Beck1, R Giess, W Würffel, T Magnus, G Ochs, K V Toyka.   

Abstract

Maximal voluntary isometric contraction (MVIC) is a standard tool for assessment of muscle strength in treatment trials for amyotrophic lateral sclerosis (ALS). There is need for more practical bedside techniques especially for severely disabled patients. Hand-held dynamometry (HH-Dyn) is an inexpensive and easy-to-handle device. MVIC was measured in five proximal muscle groups bilaterally and compared with HH-Dyn in 43 ALS patients. After a training period we found good intrarater correlation for HH-Dyn (r = 0.99), with a low coefficient of variation. Measurements tended to become more accurate after repeated testing due to practice effects in examiners and patients. Overall correlation between HH-Dyn and MVIC was good [r = 0.85 (P < 0.01)]. Strength-range-specific analysis showed a significant linear correlation up to 20 kg (44 lbs.) [r = 0.57 (P < 0.01)]. However, we found a tendency to underestimate muscle strength above 10 kg by HH-Dyn as compared with MVIC, but this became meaningful only above a force of 20 kg. HH-Dyn provides a strength estimate with a precision close to MVIC in weak muscle groups (MRC grade 4). With standardization and appropriate training, HH-Dyn is a useful bedside test, providing an alternative to MVIC for follow-up assessment in ALS. Copyright 1999 John Wiley & Sons, Inc.

Entities:  

Mesh:

Year:  1999        PMID: 10454724     DOI: 10.1002/(sici)1097-4598(199909)22:9<1265::aid-mus15>3.0.co;2-f

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  15 in total

1.  Hip- and knee-strength assessments using a hand-held dynamometer with external belt-fixation are inter-tester reliable.

Authors:  Kristian Thorborg; Thomas Bandholm; Per Hölmich
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-07-07       Impact factor: 4.342

Review 2.  Measures and markers in amyotrophic lateral sclerosis.

Authors:  Merit Cudkowicz; Muhammad Qureshi; Jeremy Shefner
Journal:  NeuroRx       Date:  2004-04

Review 3.  Clinical Measures of Disease Progression in Amyotrophic Lateral Sclerosis.

Authors:  Seward B Rutkove
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

4.  Speech network regional involvement in bulbar ALS: a multimodal structural MRI study.

Authors:  Sanjana Shellikeri; Matthew Myers; Sandra E Black; Agessandro Abrahao; Lorne Zinman; Yana Yunusova
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2019-05-14       Impact factor: 4.092

5.  New considerations in the design of clinical trials for amyotrophic lateral sclerosis.

Authors:  James D Berry; Merit E Cudkowicz
Journal:  Clin Investig (Lond)       Date:  2011-10

6.  Outcome measures in amyotrophic lateral sclerosis clinical trials.

Authors:  Sabrina Paganoni; Merit Cudkowicz; James D Berry
Journal:  Clin Investig (Lond)       Date:  2014

7.  Treatment of IgM antibody associated polyneuropathies using rituximab.

Authors:  A Pestronk; J Florence; T Miller; R Choksi; M T Al-Lozi; T D Levine
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-04       Impact factor: 10.154

8.  In vivo myograph measurement of muscle contraction at optimal length.

Authors:  Niels Rahe-Meyer; Christian Weilbach; Matthias Karst; Matthias Pawlak; Aminul Ahmed; Siegfried Piepenbrock; Michael Winterhalter
Journal:  Biomed Eng Online       Date:  2007-01-02       Impact factor: 2.819

9.  Assessment of precision and reproducibility of a new myograph.

Authors:  Niels Rahe-Meyer; Michael Winterhalter; Aminul I Ahmed; Christian Weilbach; Matthias Gross; Siegfried Piepenbrock; Matthias Pawlak
Journal:  Biomed Eng Online       Date:  2007-12-20       Impact factor: 2.819

10.  Muscle contractility dysfunction precedes loss of motor unit connectivity in SOD1(G93A) mice.

Authors:  Christopher G Wier; Alexander E Crum; Anthony B Reynolds; Chitra C Iyer; Deepti Chugh; Marilly S Palettas; Patrick L Heilman; David M Kline; W David Arnold; Stephen J Kolb
Journal:  Muscle Nerve       Date:  2018-12-21       Impact factor: 3.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.